Literature DB >> 18797815

MHC-I-restricted epitopes conserved among variola and other related orthopoxviruses are recognized by T cells 30 years after vaccination.

S T Tang1, M Wang, K Lamberth, M Harndahl, M H Dziegiel, M H Claesson, S Buus, O Lund.   

Abstract

It is many years since the general population has been vaccinated against smallpox virus. Here, we report that human leukocyte antigen (HLA) class I restricted T cell epitopes can be recognized more than 30 years after vaccination. Using bioinformatic methods, we predicted 177 potential cytotoxic T lymphocyte epitopes. Eight epitopes were confirmed to stimulate IFN-gamma release by T cells in smallpox-vaccinated subjects. The epitopes were restricted by five supertypes (HLA-A1, -A2, -A24 -A26 and -B44). Significant T cell responses were detected against 8 of 45 peptides with an HLA class I affinity of K(D) less than or equal to 5 nM, whereas no T cell responses were detected against 60 peptides with an HLA affinity of K(D) more than 5 nM. All epitopes were fully conserved in seven variola, vaccinia and cowpox strains. Knowledge of the long-term response to smallpox vaccination may lead to a better understanding of poxvirus immunity and may aid in the development of new improved vaccines and diagnostic tools.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18797815      PMCID: PMC2784598          DOI: 10.1007/s00705-008-0194-7

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  50 in total

1.  Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells.

Authors:  Rama Rao Amara; Pragati Nigam; Sunita Sharma; Jinyan Liu; Vanda Bostik
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

2.  An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions.

Authors:  Mette Voldby Larsen; Claus Lundegaard; Kasper Lamberth; Søren Buus; Søren Brunak; Ole Lund; Morten Nielsen
Journal:  Eur J Immunol       Date:  2005-08       Impact factor: 5.532

3.  Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.

Authors:  D Huw Davies; Megan M McCausland; Conrad Valdez; Devan Huynh; Jenny E Hernandez; Yunxiang Mu; Siddiqua Hirst; Luis Villarreal; Philip L Felgner; Shane Crotty
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

4.  Identification of murine poxvirus-specific CD8+ CTL epitopes with distinct functional profiles.

Authors:  Anuja Mathew; Masanori Terajima; Kim West; Sharone Green; Alan L Rothman; Francis A Ennis; Jeffrey S Kennedy
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

5.  Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.

Authors:  James T Snyder; Igor M Belyakov; Amiran Dzutsev; François Lemonnier; Jay A Berzofsky
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

6.  Poxvirus genomes: a phylogenetic analysis.

Authors:  Caroline Gubser; Stéphane Hué; Paul Kellam; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2004-01       Impact factor: 3.891

7.  Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors.

Authors:  Gary DiPerna; Julianne Stack; Andrew G Bowie; Annemarie Boyd; Girish Kotwal; Zhouning Zhang; Sheila Arvikar; Eicke Latz; Katherine A Fitzgerald; William L Marshall
Journal:  J Biol Chem       Date:  2004-06-23       Impact factor: 5.157

8.  Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers.

Authors:  Inese Cebere; Lucy Dorrell; Helen McShane; Alison Simmons; Sheena McCormack; Claudia Schmidt; Carol Smith; Mary Brooks; Joanna E Roberts; Simon C Darwin; Patricia E Fast; Christopher Conlon; Sarah Rowland-Jones; Andrew J McMichael; Tomás Hanke
Journal:  Vaccine       Date:  2005-08-24       Impact factor: 3.641

9.  Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans.

Authors:  Behazine Combadiere; Alexandre Boissonnas; Guislaine Carcelain; Evelyne Lefranc; Assia Samri; François Bricaire; Patrice Debre; Brigitte Autran
Journal:  J Exp Med       Date:  2004-06-07       Impact factor: 14.307

10.  SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation.

Authors:  C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus
Journal:  Tissue Antigens       Date:  2004-05
View more
  12 in total

Review 1.  Major histocompatibility complex class I binding predictions as a tool in epitope discovery.

Authors:  Claus Lundegaard; Ole Lund; Søren Buus; Morten Nielsen
Journal:  Immunology       Date:  2010-05-26       Impact factor: 7.397

2.  High-affinity human leucocyte antigen class I binding variola-derived peptides induce CD4+ T cell responses more than 30 years post-vaccinia virus vaccination.

Authors:  M Wang; S T Tang; O Lund; M H Dziegiel; S Buus; M H Claesson
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

3.  Prediction of epitopes using neural network based methods.

Authors:  Claus Lundegaard; Ole Lund; Morten Nielsen
Journal:  J Immunol Methods       Date:  2010-10-31       Impact factor: 2.303

4.  Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.

Authors:  Mingjun Wang; Sheila T Tang; Anette Stryhn; Sune Justesen; Mette V Larsen; Morten H Dziegiel; David M Lewinsohn; Søren Buus; Ole Lund; Mogens H Claesson
Journal:  Immunology       Date:  2011-02-07       Impact factor: 7.397

5.  HLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responses.

Authors:  Mingjun Wang; Mette V Larsen; Morten Nielsen; Mikkel Harndahl; Sune Justesen; Morten H Dziegiel; Søren Buus; Sheila T Tang; Ole Lund; Mogens H Claesson
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

6.  NetCTLpan: pan-specific MHC class I pathway epitope predictions.

Authors:  Thomas Stranzl; Mette Voldby Larsen; Claus Lundegaard; Morten Nielsen
Journal:  Immunogenetics       Date:  2010-04-09       Impact factor: 2.846

7.  Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system.

Authors:  Nicolas Rapin; Ole Lund; Massimo Bernaschi; Filippo Castiglione
Journal:  PLoS One       Date:  2010-04-16       Impact factor: 3.240

8.  HLA haplotype and supertype associations with cellular immune responses and cytokine production in healthy children after rubella vaccine.

Authors:  Inna G Ovsyannikova; Robert A Vierkant; V Shane Pankratz; Megan M O'Byrne; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2009-02-05       Impact factor: 3.641

9.  Identification of CD8+ T cell epitopes in the West Nile virus polyprotein by reverse-immunology using NetCTL.

Authors:  Mette Voldby Larsen; Alina Lelic; Robin Parsons; Morten Nielsen; Ilka Hoof; Kasper Lamberth; Mark B Loeb; Søren Buus; Jonathan Bramson; Ole Lund
Journal:  PLoS One       Date:  2010-09-14       Impact factor: 3.240

10.  A novel composite immunotoxin that suppresses rabies virus production by the infected cells.

Authors:  Tatiana Mareeva; Celestine Wanjalla; Matthias J Schnell; Yuri Sykulev
Journal:  J Immunol Methods       Date:  2009-11-22       Impact factor: 2.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.